LexaGene Holdings Inc. (LXG) Plunged -0.96% on Feb 14

February 14, 2018 - By Winifred Garcia

Shares of LexaGene Holdings Inc. (CVE:LXG) last traded at 1.03, representing a move of -0.96%, or -0.01 per share, on volume of 23,810 shares. After opening the trading day at 1.04, shares of LexaGene Holdings Inc. traded in a close range. LexaGene Holdings Inc. currently has a total float of 48.94 million shares and on average sees 107,617 shares exchange hands each day. The stock now has a 52-week low of 0.37 and high of 1.64.

What Drives The Canadian Economy?

Canada is an important aspect of the North American economy. While the US is relatively bigger, it still has interesting potentials to drive economic growth in the region.
With a thriving equity market, any nation has the capacity to carry out long-term prospects. In Canada, for example, there is the Toronto Stock Exchange (TSX). The benchmark index is the S&P/TSX Composite Index, replacing the TSE 300 Index.

Facts About the S&P/TSX Composite Index

The S&P/TSX Composite Index is a free-float market-capitalization-weighted index like most leading indices in the world. This means that its components are the most actively traded stocks on the TSX, excluding those that are held by inside traders, venture capitalists, and government entities. Stocks held by these stakeholders are not frequently traded, which is why it is useless to include them on indices. LexaGene Holdings Inc. is one of the stocks traded on it.

The S&P/TSX Composite Index had recorded its all-time high of 15,657.63 in September 2014, thanks to the gains in crude oil prices that primarily led the surge in the Energy and Financials sectors’ the two biggest sectors on the weighted index. Meanwhile, it had recorded its all-time low of 217.50 in February 1950. As of October 31, 2014, more than 1,500 companies are listed on the TSX. By the end of May, the TSX already had a market capitalization of $2.78 trillion. The regular trading session on the TSX begins at 9:30 a.m. and ends at 4:00 p.m. There is also a post-market session that lasts from 4:15 p.m. until 5:00 p.m.

What Makes Up the S&P/TSX Composite Index

There are numerous requirements in order for companies to be included in the S&P/TSX Composite Index. For starters, of course, they need to be listed on the TSX. Consequently, they must operate in accordance to all existing Canadian corporate laws. As LexaGene Holdings Inc. is still listed, this means that the stock complies with all laws.

In order to become a component of the S&P/TSX Composite Index, a stock must weigh at least 0.05% of the index. Prior to rebalancing, it must have traded an average of C$1 in the preceding three months and at least C$1 in the last three sessions leading to the month of review. Moreover, its trading volume must weigh at least 0.025% of the overall trading volume of all eligible stocks.

About 250 companies make up the S&P/TSX Composite Index. The Financials and Energy sectors alone account for 56% of it, with the former making up 36% and the latter making up 20%. The next biggest sectors include the Materials, Industrial, and Consumer Discretionary sectors.

Because the Organization of the Petroleum Exporting Countries (OPEC) has recently decided to cut oil production rate to lift oil prices, the Energy sector of the S&P/TSX Composite Index is poised for potential gains. Professional analysts might be interested how this will affect LexaGene Holdings Inc..

Investing on the TSX is an ideal way to bet on the Canadian economy. With a promising long-term growth, investors will surely benefit from valuable returns be it in the near term or the longer term.

More notable recent LexaGene Holdings Inc. (CVE:LXG) news were published by: Globenewswire.com which released: “LexaGene Holdings Inc. Announces Closing of Over-Allotment Option” on January 22, 2018, also Globenewswire.com with their article: “LexaGene Holdings Inc. Announces Closing of C$5.0 Million Bought Deal Financing” published on December 19, 2017, Globenewswire.com published: “LexaGene Appoints Nathan Walsh to Director of Applications – Bioinformatics …” on February 13, 2018. More interesting news about LexaGene Holdings Inc. (CVE:LXG) were released by: Globenewswire.com and their article: “LexaGene unaware of any material change” published on October 12, 2017 as well as Marketwired.com‘s news article titled: “LexaGene Announces Website Launch” with publication date: February 07, 2017.

Lexagene Holdings Inc. engages in the research, development, and commercialization of pathogen detection devices to the bio-chemical industry in the United States. The company has market cap of $50.41 million.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: